April 01, 2025FinancialTerumo announces changes to the names of some businesses within the Cardiac and Vascular Company (PDF 117.21 KB) Disclosure segments of Blood and Cell Technologies Company to also be revised
April 01, 2025CorporateTerumo unveils "Our Promise," the long-term direction to be pursued by the entire groupThe company also launches a group brand video and visuals that express its unwavering commitment to improving patients’ lives
March 31, 2025CorporateTerumo opens new R&D center in the U.S. to strengthen global innovation capabilities
Investors Japanese Financial Results for the Third Quarter of the Fiscal Year Ending 3/2025 Feb. 13, 2025 IR Library Audio Webcast Stock Quote Prime Market of TSE: Last Trade JPY Change JPY (%) Volume View Chart Top Management Message Hikaru Samejima Chief Executive Officer GS26: 5-Year Growth strategy 2022 - 2026 IR Library IR materials and various reports Terumo Report Integrated Report 2024 Sustainability Sustainability at the Terumo Group From Devices to Solutions Vision for the Next 10 Years Shareholders & Stock Information on shareholders meeting and stock What's New April 01, 2025 Terumo announces changes to the names of some businesses within the Cardiac and Vascular Company (PDF 117.21 KB) Disclosure segments of Blood and Cell Technologies Company to also be revised February 14, 2025 Audio webcast and Q&A regarding Financial Results for the Third Quarter of FYE 3/2025 February 13, 2025 Presentation regarding Financial Results for the Third Quarter of FYE 3/2025 December 03, 2024 Notice Concerning Status of Acquisition of Own Shares (PDF 88.66 KB) (Acquisition of the Company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan) November 08, 2024 Audio webcast and Q&A regarding Financial Results for the Second Quarter of FYE 3/2025 View all Business Overview Introduction to the businesses operated by the Terumo Group /business Technology Introduction to Terumo's research and development activities and production system /technology
April 01, 2025 Terumo announces changes to the names of some businesses within the Cardiac and Vascular Company (PDF 117.21 KB) Disclosure segments of Blood and Cell Technologies Company to also be revised
February 14, 2025 Audio webcast and Q&A regarding Financial Results for the Third Quarter of FYE 3/2025
December 03, 2024 Notice Concerning Status of Acquisition of Own Shares (PDF 88.66 KB) (Acquisition of the Company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan)
November 08, 2024 Audio webcast and Q&A regarding Financial Results for the Second Quarter of FYE 3/2025
